BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38556572)

  • 1. Analysis of circulating osteoclast and osteogenic precursors in patients with Gorham-Stout disease.
    Rossi M; Terreri S; Battafarano G; Rana I; Buonuomo PS; Di Giuseppe L; D'Agostini M; Porzio O; Di Gregorio J; Cipriani C; Jenkner A; Gonfiantini MV; Bartuli A; Del Fattore A
    J Endocrinol Invest; 2024 Apr; ():. PubMed ID: 38556572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissecting the mechanisms of bone loss in Gorham-Stout disease.
    Rossi M; Buonuomo PS; Battafarano G; Conforti A; Mariani E; Algeri M; Pelle S; D'Agostini M; Macchiaiolo M; De Vito R; Gonfiantini MV; Jenkner A; Rana I; Bartuli A; Del Fattore A
    Bone; 2020 Jan; 130():115068. PubMed ID: 31525474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and humoral mechanisms of osteoclast formation and bone resorption in Gorham-Stout disease.
    Hirayama T; Sabokbar A; Itonaga I; Watt-Smith S; Athanasou NA
    J Pathol; 2001 Dec; 195(5):624-30. PubMed ID: 11745700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulated miRNAs in bone cells of patients with Gorham-Stout disease.
    Rossi M; Rana I; Buonuomo PS; Battafarano G; Mariani E; D'Agostini M; Porzio O; De Martino V; Minisola S; Macchiaiolo M; De Vito R; Vecchio D; Gonfiantini MV; Jenkner A; Bartuli A; Del Fattore A
    FASEB J; 2021 Mar; 35(3):e21424. PubMed ID: 33609323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D(3) and RANKL.
    Neale SD; Smith R; Wass JA; Athanasou NA
    Bone; 2000 Sep; 27(3):409-16. PubMed ID: 10962353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6: a potential mediator of the massive osteolysis in patients with Gorham-Stout disease.
    Devlin RD; Bone HG; Roodman GD
    J Clin Endocrinol Metab; 1996 May; 81(5):1893-7. PubMed ID: 8626854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
    Michael H; Härkönen PL; Väänänen HK; Hentunen TA
    J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viewpoints on vessels and vanishing bones in Gorham-Stout disease.
    Dellinger MT; Garg N; Olsen BR
    Bone; 2014 Jun; 63():47-52. PubMed ID: 24583233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone impairment in phenylketonuria is characterized by circulating osteoclast precursors and activated T cell increase.
    Roato I; Porta F; Mussa A; D'Amico L; Fiore L; Garelli D; Spada M; Ferracini R
    PLoS One; 2010 Nov; 5(11):e14167. PubMed ID: 21152388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating mediators of bone remodeling in psoriatic arthritis: implications for disordered osteoclastogenesis and bone erosion.
    Dalbeth N; Pool B; Smith T; Callon KE; Lobo M; Taylor WJ; Jones PB; Cornish J; McQueen FM
    Arthritis Res Ther; 2010; 12(4):R164. PubMed ID: 20796300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD14+ CD16+ monocytes rather than CD14+ CD51/61+ monocytes are a potential cytological marker of circulating osteoclast precursors in multiple myeloma. A preliminary study.
    Petitprez V; Royer B; Desoutter J; Guiheneuf E; Rigolle A; Marolleau JP; Kamel S; Guillaume N
    Int J Lab Hematol; 2015 Feb; 37(1):29-35. PubMed ID: 24661393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors.
    Shalhoub V; Faust J; Boyle WJ; Dunstan CR; Kelley M; Kaufman S; Scully S; Van G; Lacey DL
    J Cell Biochem; 1999 Feb; 72(2):251-61. PubMed ID: 10022507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of osteoprotegerin and osteoprotegerin ligand on osteoclast formation by arthroplasty membrane derived macrophages.
    Itonaga I; Sabokbar A; Murray DW; Athanasou NA
    Ann Rheum Dis; 2000 Jan; 59(1):26-31. PubMed ID: 10627423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased osteoclast formation and activity by peripheral blood mononuclear cells in chronic liver disease patients with osteopenia.
    Olivier BJ; Schoenmaker T; Mebius RE; Everts V; Mulder CJ; van Nieuwkerk KM; de Vries TJ; van der Merwe SW
    Hepatology; 2008 Jan; 47(1):259-67. PubMed ID: 18022900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of rosiglitazone vs metformin on circulating osteoclast and osteogenic precursor cells in postmenopausal women with type 2 diabetes mellitus.
    Rubin MR; Manavalan JS; Agarwal S; McMahon DJ; Nino A; Fitzpatrick LA; Bilezikian JP
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E1933-42. PubMed ID: 24905061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of Treg Cells to Inhibit Osteoclastogenesis in Gorham-Stout Disease.
    Rossi M; Rana I; Buonuomo PS; Battafarano G; De Martino V; D'Agostini M; Porzio O; Cipriani C; Minisola S; De Vito R; Vecchio D; Gonfiantini MV; Jenkner A; Bartuli A; Del Fattore A
    Front Cell Dev Biol; 2021; 9():706596. PubMed ID: 34513837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced expression of semaphorin 3A in osteoclasts causes lymphatic expansion in a Gorham-Stout disease (GSD) mouse model.
    Zhang D; Xu H; Qin C; Cai K; Zhang J; Xia X; Bi J; Zhang L; Xing L; Liang Q; Wang W
    J Zhejiang Univ Sci B; 2024 Jan; 25(1):38-50. PubMed ID: 38163665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD14- mononuclear stromal cells support (CD14+) monocyte-osteoclast differentiation in aneurysmal bone cyst.
    Taylor RM; Kashima TG; Hemingway FK; Dongre A; Knowles HJ; Athanasou NA
    Lab Invest; 2012 Apr; 92(4):600-5. PubMed ID: 22330339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoprotegerin (OPG) and receptor activator of NF-kB ligand (RANK-L) serum levels in patients on chronic hemodialysis.
    Gonnelli S; Montagnani A; Caffarelli C; Cadirni A; Campagna MS; Franci MB; Lucani B; Gaggiotti E; Nuti R
    J Endocrinol Invest; 2005 Jun; 28(6):534-9. PubMed ID: 16117195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.